Open
24.9 2.55
24h
Min
23.91
Max
24.79
Income | 28M -13M |
---|---|
Sales | 33M 114M |
Profit margin | -11.145 |
Employees | 385 |
EBITDA | 13M -13M |
Recommendations | Strong Buy |
---|---|
12 Months Forecast | +40.26% upside |
Next Earnings | 30 paź 2025 |
---|
Market Cap | 838M 2.3B |
---|---|
Previous open | 22.35 |
Previous close | 24.9 |
By Trading Central
Confidence
Weak Bullish Evidence
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Price change
By TipRanks
12 Months Forecast
Average 34.77 USD 40.26%
High 47 USD
Low 25 USD
Based on 16 Wall Street analysts offering 12 month price targets forTravere Therapeutics Inc - Dist in the last 3 months.
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$